EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H28N6O2 |
| Net Charge | 0 |
| Average Mass | 396.495 |
| Monoisotopic Mass | 396.22737 |
| SMILES | CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12 |
| InChI | InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1 |
| InChIKey | PIMQWRZWLQKKBJ-SFHVURJKSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22). apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dinaciclib (CHEBI:95060) has role antineoplastic agent (CHEBI:35610) |
| dinaciclib (CHEBI:95060) has role apoptosis inducer (CHEBI:68495) |
| dinaciclib (CHEBI:95060) has role EC 2.7.11.22 (cyclin-dependent kinase) inhibitor (CHEBI:82665) |
| dinaciclib (CHEBI:95060) is a piperidines (CHEBI:26151) |
| dinaciclib (CHEBI:95060) is a primary alcohol (CHEBI:15734) |
| dinaciclib (CHEBI:95060) is a pyrazolopyrimidine (CHEBI:38669) |
| dinaciclib (CHEBI:95060) is a pyridine N-oxides (CHEBI:38189) |
| dinaciclib (CHEBI:95060) is a secondary amino compound (CHEBI:50995) |
| dinaciclib (CHEBI:95060) is a tertiary amino compound (CHEBI:50996) |
| IUPAC Name |
|---|
| 2-[(2S)-1-(3-ethyl-7-{[(1-oxidopyridin-3-yl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)piperidin-2-yl]ethanol |
| INNs | Source |
|---|---|
| dinaciclib | WHO MedNet |
| dinaciclib | WHO MedNet |
| dinaciclib | WHO MedNet |
| dinaciclibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| 2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol | ChEBI |
| (2S)-1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol | ChEBI |
| MK 7965 | ChEBI |
| MK-7965 | ChEBI |
| MK7965 | ChEBI |
| SCH 727965 | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| 1QK | PDBeChem |
| D09604 | KEGG DRUG |
| DB12021 | DrugBank |
| Dinaciclib | Wikipedia |
| LSM-6306 | LINCS |
| Registry Numbers | Sources |
|---|---|
| CAS:779353-01-4 | DrugBank |
| Citations |
|---|